Bumrungrad Hospital Public Company Limited reported earnings results for the third quarter and nine months ended September 30, 2025. For the third quarter, the company reported sales was THB 6,512.61 million compared to THB 6,405.17 million a year ago. Revenue was THB 6,581.5 million compared to THB 6,446.51 million a year ago. Net income was THB 2,034.95 million compared to THB 1,955.14 million a year ago. Basic earnings per share from continuing operations was THB 2.56 compared to THB 2.46 a year ago. Diluted earnings per share from continuing operations was THB 2.35 compared to THB 2.25 a year ago.
For the nine months, sales was THB 18,677.63 million compared to THB 19,244.41 million a year ago. Revenue was THB 18,890.29 million compared to THB 19,343 million a year ago. Net income was THB 5,626.42 million compared to THB 5,871.77 million a year ago. Basic earnings per share from continuing operations was THB 7.08 compared to THB 7.39 a year ago. Diluted earnings per share from continuing operations was THB 6.49 compared to THB 6.77 a year ago.
Bumrungrad Hospital Public Company Limited is a healthcare provider in Thailand and Southeast Asia, providing holistic and healthcare services for both outpatients and inpatients. The Company operates through a hospital and health care center business. It operates a private hospital business in Bangkok with 580 inpatient beds and a capacity for over 5,500 outpatients per day. Its Telemedicine service provides consultation through information technology to support remote access consultation. Its preventive genomics and family check-up services provide diagnosis, treatment, and advice, including risk assessment and screening for diseases caused by genetic abnormalities. Its Bumrungrad@Home service provides health care services. Its Breast Center delivers holistic medical services regarding breast health for all genders. Its sports medicine and joint center offer an integrated approach to treating musculoskeletal problems.
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
